Experience - mblhealth.co.uk

Our Rare Disease Experience

Canavan Disease Gene Therapy Clinical Trial

Congenital Adrenal Hyperplasia (CAH) Gene Therapy Clinical Trial

Myasthenia gravis Phase 2/3 Clinical Trial

Ornithine Transcarbamylase Deficiency (OTCD) Phase 2/3 Clinical Trial

Generalized pustular psoriasis (GPP) Real World Data

Warm antibody hemolytic anemia (wAIHA) Real World Data

DUP15q Real World Data

Myositis Real World Data

Idiopathic pulmonary fibrosis (IPF) Phase 2/3 Clinical Trial

Pouchitis Phase 2/3 Clinical Trial

Sickle Cell Digital Campaigns

Friedreich ataxia (FA) Digital Campaigns

We've Randomized Patients Across Different Countries

Our patient engagement solutions enable us to craft tailored,
omnichannel communications to support your drug
development, post-approval research, or commercialization effort.

Next chapter

Bring your
trial forward.

We help biotech and pharma teams build digital-first recruitment ecosystems for rare disease and gene therapy programs.

We work as an extension of your team.

Our purpose is to digitally transform sponsor-patient connections, accelerating medical research, all while putting the ‘Human’ in HealthTech

Our Rare Disease Experience

We've Randomized Patients Across Different Countries

Bring your
trial forward.

We work as an extension of your team.

Our purpose is to digitally transform sponsor-patient connections, accelerating medical research, all while putting the ‘Human’ in HealthTech

Our Rare Disease Experience

We've Randomized Patients Across Different Countries

Bring your trial forward.

Bring your
trial forward.